Soluble Leptin Receptor (sLEP-R) ELISA

Este producto es parte de LEPR - leptin receptor
Product Graph
560€ (96 det.)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Soluble Leptin Receptor (sLEP-R) ELISA
category
ELISA Kits
provider
Mediagnost
reference
R07
tested applications
Elisa

Description

Quantitative measurement of soluble human leptin receptor (sLEP-R) in human serum or plasma for research purposes.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Human
Assay Data
Reference Material:  Recombinant eukaryotically expressed soluble leptin receptor.
Incubation Period:  5 h
Calibrator:  8 individual standards, 0-30 ng/mL
Controls: 2 serum controls, low and high level, respectively, lyophilized
Assay Type
Sandwich
Test Range
0.0385-150 µg/L
Sensitivity
0,0385 µg/L
Recommended Dilution
1:5
Origin
Antibody:  Specific high-affinity antibodies
Size 1
96 det.
Tested Applications
Elisa
Sample Type
Serum / Plasma
Availability
3-5 days.
Storage
Shelf life: between 1 and 2 years. Inquire about availability
Store the kit at 2-8°C after receipt until its expiry date.
Alias
OBR, CD295, LEP-R
Background
Elisa Kits for: LEPR
Status
RUO
Note
Intra/Interassay Variance [%] < 10%

Descripción

Soluble Leptin Receptor (sLEP-R) ELISA permite la medición cuantitativa del receptor de leptina humano soluble (sLEP-R) en suero o plasma humano con fines de investigación.

The adipokine leptin realizes signal transduction via four different leptin receptor (LEP-R) isoforms. The amount of functionally active LEP-R, however, is affected by constitutive shedding of the extracellular domain. The product of the cleavage process, the so-called soluble leptin receptor (sLEP-R, soluble Leptin receptor), is the main binding protein for leptin in human blood and modulates its bioavailability. Concentrations of sLEP-R are differentially regulated in metabolic disorders, such as type 1 diabetes mellitus or obesity and can therefore enhance or reduce leptin sensitivity. Lipotoxicity and apoptosis increase LEP-R cleavage via ADAM10-dependent mechanisms. In contrast, although increased sLEP-R concentrations seem directly to inhibit leptin effects, reduced amounts of sLEP-R may reflect decreased membrane expression of LEP-R. These findings, in part, explain alterations of leptin sensitivity that are associated with changes in serum sLEP-R concentrations seen in metabolic disorders.

Related Products

E103

Human Progranulin ELISA

The Mediagnost Progranulin ELISA is an assay with good reproducibility that detects progranulin and not granulins with high specificity in human Serum and Plasma Samples for research use.

Ver Producto
E106

Human Vaspin ELISA

Mediagnost ELISA for quantitative measurement of Vaspin in human serum is based on polyclonal rabbit antisera raised by genetic immunization of the rabbits (cDNA Vaspin SC306941).For Research Use Only. Not for Diagnostic

Ver Producto
L07

Functional Leptin Elisa

bioLEP ELISA a test for the measurement of biologically active leptinHere, the measurement is not based on two specific antibodies, but on the combination of a specific, polyclonal anit leptin antibody with the Leptin binding protein, the extracellular part of the leptin receptor. In this way, the test allows to measure only the functional leptin that is able to bind to the receptor

Ver Producto